D-serine added to clozapine for the treatment of schizophrenia

American Journal of Psychiatry

Volumn 156, Issue 11, 1999, Pages 1822-1825

  Tsai, Guochuan E ^a   Yang, Pinchen ^b   Chung, Li Chen ^b   Tsai, I Ching ^b   Tsai, Chung Wen ^b   Coyle, Joseph T ^b  

^a MCLEAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CLOZAPINE; CYCLOSERINE; DEXTRO SERINE; GLUTAMIC ACID; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; PLACEBO; SERINE;

ADULT; AKATHISIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NEGATIVE SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG THERAPY, COMBINATION; GLYCINE; HUMANS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SERINE;

EID: 0032700978     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Coyle JT: The glutamatergic dysfunction hypothesis for schizophrenia. Harvard Rev Psychiatry 1996; 3:241-253
2. Tsai G, Yang P, Chung L, Lange N, Coyle JT: D-Serine added to antipsychotic for the treatment of schizophrenia. Biol Psychiatry 1998; 44:1081-1089
3. Goff DC, Tsai G, Levitt J, Amico E, Manoach DS, Schoenfeld D, Hayden DL, McCarley R, Coyle JT: A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry 1999; 56: 21-27
4. Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G, Lichtenstein M: Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry 1999; 56:29-36
5. Goff DC, Tsai G, Manoach DS, Flood J, Darby DG, Coyle JT: D-Cycloserine added to clozapine for patients with schizophrenia. Am J Psychiatry 1996; 153:1628-1630
6. Kane J, Honigfeld G, Singer J, Meltzer H: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789-796
7. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr: The Schedule for the Deficit Syndrome: an instrument for research in schizophrenia. Psychiatry Res 1989; 30:119-123
8. Potkin SG, Jin Y, Bunney BG, Costa J, Gulasekaram B: Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia. Am J Psychiatry 1999; 156:145-147
9. Simeon J, Fink M, Itil TM, Ponce D: D-Cycloserine therapy of psychosis by symptom provocation. Compr Psychiatry 1970; 11:80-88
10. van Berckel BN, Evenblij CN, van Loon BJ, Maas MF, van der Geld MA, Wynne HJ, van Ree JM, Kahn RS: D-Cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: a double-blind, parallel, placebo-controlled study. Neuropsychopharmacology 1999; 21:203-210
11. Goff DC, Tsai G, Manoach DS, Coyle JT: A dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry 1995; 152:1213-1215
12. Banerjee SP, Zuck LG, Yablonsky-Alter E, Lidsky TI: Glutamate agonist activity: implications for antipsychotic drug action and schizophrenia. Neuroreport 1995; 6:2500-2504